OBJECTIVE: To determine the prevalence of Acinetobacter baumannii, an important healthcare-associated pathogen, among mechanically ventilated patients in Maryland. DESIGN: The Maryland MDRO Prevention Collaborative performed a statewide cross-sectional active surveillance survey of mechanically ventilated patients residing in acute care and long-term care (LTC) facilities. Surveillance cultures (sputum and perianal) were obtained from all mechanically ventilated inpatients at participating facilities during a 2-week period. SETTING: All healthcare facilities in Maryland that provide care for mechanically ventilated patients were invited to participate. PATIENTS: Mechanically ventilated patients, known to be at high risk for colonization and infection with A. baumannii, were included. RESULTS: Seventy percent (40/57) of all eligible healthcare facilities participated in the survey, representing both acute care ([Formula: see text]) and LTC ([Formula: see text]) facilities in all geographic regions of Maryland. Surveillance cultures were obtained from 92% (358/390) of eligible patients. A. baumannii was identified in 34% of all mechanically ventilated patients in Maryland; multidrug-resistant A. baumannii was found in 27% of all patients. A. baumannii was detected in at least 1 patient in 49% of participating facilities; 100% of LTC facilities had at least 1 patient with A. baumannii, compared with 31% of acute care facilities. A. baumannii was identified from all facilities in which 10 or more patients were sampled. CONCLUSIONS: A. baumannii is common among mechanically ventilated patients in both acute care and LTC facilities throughout Maryland, with a high proportion of isolates demonstrating multidrug resistance.
OBJECTIVE: To determine the prevalence of Acinetobacter baumannii, an important healthcare-associated pathogen, among mechanically ventilated patients in Maryland. DESIGN: The Maryland MDRO Prevention Collaborative performed a statewide cross-sectional active surveillance survey of mechanically ventilated patients residing in acute care and long-term care (LTC) facilities. Surveillance cultures (sputum and perianal) were obtained from all mechanically ventilated inpatients at participating facilities during a 2-week period. SETTING: All healthcare facilities in Maryland that provide care for mechanically ventilated patients were invited to participate. PATIENTS: Mechanically ventilated patients, known to be at high risk for colonization and infection with A. baumannii, were included. RESULTS: Seventy percent (40/57) of all eligible healthcare facilities participated in the survey, representing both acute care ([Formula: see text]) and LTC ([Formula: see text]) facilities in all geographic regions of Maryland. Surveillance cultures were obtained from 92% (358/390) of eligible patients. A. baumannii was identified in 34% of all mechanically ventilated patients in Maryland; multidrug-resistant A. baumannii was found in 27% of all patients. A. baumannii was detected in at least 1 patient in 49% of participating facilities; 100% of LTC facilities had at least 1 patient with A. baumannii, compared with 31% of acute care facilities. A. baumannii was identified from all facilities in which 10 or more patients were sampled. CONCLUSIONS:A. baumannii is common among mechanically ventilated patients in both acute care and LTC facilities throughout Maryland, with a high proportion of isolates demonstrating multidrug resistance.
Authors: A-P Magiorakos; A Srinivasan; R B Carey; Y Carmeli; M E Falagas; C G Giske; S Harbarth; J F Hindler; G Kahlmeter; B Olsson-Liljequist; D L Paterson; L B Rice; J Stelling; M J Struelens; A Vatopoulos; J T Weber; D L Monnet Journal: Clin Microbiol Infect Date: 2011-07-27 Impact factor: 8.067
Authors: M Denton; M H Wilcox; P Parnell; D Green; V Keer; P M Hawkey; I Evans; P Murphy Journal: Intensive Crit Care Nurs Date: 2005-01-21 Impact factor: 3.072
Authors: F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan Journal: J Clin Microbiol Date: 1995-09 Impact factor: 5.948
Authors: Andrew E Simor; Mark Lee; Mary Vearncombe; Linda Jones-Paul; Clare Barry; Manuel Gomez; Joel S Fish; Robert C Cartotto; Robert Palmer; Marie Louie Journal: Infect Control Hosp Epidemiol Date: 2002-05 Impact factor: 3.254
Authors: Jon P Furuno; Joan N Hebden; Harold C Standiford; Eli N Perencevich; Ram R Miller; Anita C Moore; Sandra M Strauss; Anthony D Harris Journal: Am J Infect Control Date: 2008-09 Impact factor: 2.918
Authors: Eli N Perencevich; Jessina C McGregor; Michelle Shardell; Jon P Furuno; Anthony D Harris; J Glenn Morris; David N Fisman; Judith A Johnson Journal: Infect Control Hosp Epidemiol Date: 2008-12 Impact factor: 3.254
Authors: G Patel; F Perez; A M Hujer; S D Rudin; J J Augustine; G H Jacobs; M R Jacobs; R A Bonomo Journal: Transpl Infect Dis Date: 2015-02-06 Impact factor: 2.228
Authors: Eva Mortensen; Kavita K Trivedi; Jon Rosenberg; Sara H Cody; Janet Long; Bette J Jensen; Duc J Vugia Journal: Infect Control Hosp Epidemiol Date: 2014-04 Impact factor: 3.254
Authors: Genevieve L Buser; P Maureen Cassidy; Margaret C Cunningham; Susan Rudin; Andrea M Hujer; Robert Vega; Jon P Furuno; Steven H Marshall; Paul G Higgins; Michael R Jacobs; Meredith S Wright; Mark D Adams; Robert A Bonomo; Christopher D Pfeiffer; Zintars G Beldavs Journal: Infect Control Hosp Epidemiol Date: 2017-09-05 Impact factor: 3.254
Authors: Kerri A Thom; Clare Rock; Sarah S Jackson; J Kristie Johnson; Arjun Srinivasan; Laurence S Magder; Mary-Claire Roghmann; Robert A Bonomo; Anthony D Harris Journal: Crit Care Med Date: 2017-07 Impact factor: 7.598
Authors: Nasia Safdar; Deverick J Anderson; Barbara I Braun; Philip Carling; Stuart Cohen; Curtis Donskey; Marci Drees; Anthony Harris; David K Henderson; Susan S Huang; Manisha Juthani-Mehta; Ebbing Lautenbach; Darren R Linkin; Jennifer Meddings; Loren G Miller; Aaron Milstone; Daniel Morgan; Sharmila Sengupta; Meera Varman; Deborah Yokoe; Danielle M Zerr Journal: Infect Control Hosp Epidemiol Date: 2014-05 Impact factor: 3.254
Authors: Chris Rowe Taitt; Tomasz A Leski; Michael G Stockelman; David W Craft; Daniel V Zurawski; Benjamin C Kirkup; Gary J Vora Journal: Antimicrob Agents Chemother Date: 2013-11-18 Impact factor: 5.191
Authors: Jennifer Townsend; An Na Park; Rita Gander; Kathleen Orr; Doramarie Arocha; Song Zhang; David E Greenberg Journal: Open Forum Infect Dis Date: 2015-03-12 Impact factor: 3.835